Literature DB >> 6736294

Topographic organization of the olivocochlear projections from the lateral and medial zones of the superior olivary complex.

J J Guinan, W B Warr, B E Norris.   

Abstract

By anterograde tracing using autoradiography, we have found topographic organizations in the projections of both medial and lateral olivocochlear (OC) systems in the cat. Lateral-zone injections show an ipsilateral cochleotopic projection pattern with more medial injections projecting more basally in the cochlea. In the contralateral cochlea, in contrast, the projections from all of the lateral-zone injections were predominantly to the apex. However, detailed analysis suggests the possibility that the contralateral lateral-zone projections may have the same cochleotopic organization as the ipsilateral projections but with a heavy bias toward the apex. Medial-zone injections show a pattern in which more dorsal regions project more basally in both cochleas. The ipsilateral projections of lateral OC neurons appear to connect regions with similar best frequencies but the projections of medial OC neurons do not. Summation of data from all of the injections in each zone indicates that lateral OC projections are relatively evenly distributed throughout the ipsilateral cochlea but are predominantly to the apex in the contralateral cochlea. Medial OC projections are predominantly to the middle and basal parts of the cochlea on both sides with contralateral projections somewhat more basal than ipsilateral projections.

Mesh:

Year:  1984        PMID: 6736294     DOI: 10.1002/cne.902260103

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  28 in total

1.  A multifrequency method for determining cochlear efferent activity.

Authors:  Anne E Luebke; Paul K Foster; Barden B Stagner
Journal:  J Assoc Res Otolaryngol       Date:  2002-03

2.  Contralateral-noise effects on cochlear responses in anesthetized mice are dominated by feedback from an unknown pathway.

Authors:  Stéphane F Maison; Hajime Usubuchi; Douglas E Vetter; A Bélen Elgoyhen; Steven A Thomas; M Charles Liberman
Journal:  J Neurophysiol       Date:  2012-04-18       Impact factor: 2.714

3.  Frequency tuning of the contralateral medial olivocochlear reflex in humans.

Authors:  Wei Zhao; Sumitrajit Dhar
Journal:  J Neurophysiol       Date:  2012-03-28       Impact factor: 2.714

4.  Recording and labeling at a site along the cochlea shows alignment of medial olivocochlear and auditory nerve tonotopic mappings.

Authors:  M Christian Brown
Journal:  J Neurophysiol       Date:  2016-01-28       Impact factor: 2.714

5.  Medial-olivocochlear-efferent inhibition of the first peak of auditory-nerve responses: evidence for a new motion within the cochlea.

Authors:  John J Guinan; Tai Lin; Holden Cheng
Journal:  J Acoust Soc Am       Date:  2005-10       Impact factor: 1.840

6.  Effects of low-frequency biasing on spontaneous otoacoustic emissions: amplitude modulation.

Authors:  Lin Bian; Kelly L Watts
Journal:  J Acoust Soc Am       Date:  2008-02       Impact factor: 1.840

7.  Experiments in macaque monkeys provide critical insights into age-associated changes in cognitive and sensory function.

Authors:  Daniel T Gray; Carol A Barnes
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-23       Impact factor: 11.205

8.  Projection from the inferior colliculus to the superior olivary complex in the albino rat.

Authors:  H Faye-Lund
Journal:  Anat Embryol (Berl)       Date:  1986

9.  Acoustic stimulation of human medial olivocochlear efferents reduces stimulus-frequency and click-evoked otoacoustic emission delays: Implications for cochlear filter bandwidths.

Authors:  Nikolas A Francis; John J Guinan
Journal:  Hear Res       Date:  2010-04-27       Impact factor: 3.208

10.  Lack of nAChR activity depresses cochlear maturation and up-regulates GABA system components: temporal profiling of gene expression in alpha9 null mice.

Authors:  Sevin Turcan; Donna K Slonim; Douglas E Vetter
Journal:  PLoS One       Date:  2010-02-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.